Controversy over stem cell therapy: NeuroGen gets interim relief from NMMC deregistration notice, health officer faces action

Published On 2023-04-13 09:58 GMT   |   Update On 2023-04-13 09:58 GMT
Advertisement

A court of the Public Health and Family Welfare Ministry has now provided interim relief to Seawoods-based Neurogen Brain and Spine Institute by staying the deregistration notice issued to the institute by Navi Mumbai Municipal Corporation (NMMC).

Apart from issuing a stay against the concerned deregistration notice, Public health minister Tanaji Sawant slammed Dr Pramod Patil and cancelled his deputation to NMMC as the medical officer of health (MOH). Besides, the institute has also sought to file an FIR against Dr Patil.

Advertisement

For more details, check out the link given below:

Controversy over Stem Cell Therapy: NeuroGen gets interim relief from NMMC deregistration notice, Health officer faces action

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News